Key result
A 43-year-old man with COVID-19 developed acute effusive pericarditis and cardiac tamponade without pulmonary involvement, which completely resolved following pericardiocentesis and treatment with colchicine and ibuprofen.
Why the study?
There is a paucity of literature describing the cardiac manifestations of COVID-19 in the absence of pulmonary findings.
Case Report (n=1)
No
Acute effusive pericarditis and cardiac tamponade can occur as a late complication of COVID-19 even in the absence of pulmonary findings, and responds well to standard pericarditis therapy.
No takes yet. Share an insight, caveat, or question.
Alerts clinicians to isolated pericardial tamponade in COVID-19; leaves open incidence and screening needs.
Fox et al. (2020) conducted a case report in COVID-19 with acute effusive pericarditis (n=1). Pericardiocentesis, colchicine, and ibuprofen was evaluated on Clinical and echocardiographic resolution of pericardial effusion. A 43-year-old man with COVID-19 developed acute effusive pericarditis and cardiac tamponade without pulmonary involvement, which completely resolved following pericardiocentesis and treatment with colchicine and ibuprofen.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: